Renin inhibitory peptides. A beta-aspartyl residue as a replacement for the histidyl residue at the P-2 site.

No abstract is available for this paper.

• Publication year

  1990

• Venue

  Journal of Medicinal Chemistry

• Publication date

  1990-05-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1021/JM00167A009PMID 2184238
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Structure of recombinant human renin, a target for cardiovascular-active drugs, at 2.5 A resolution.

  1989cited by this paper
• Renin inhibitors.

  1987cited by this paper
• Structure and refinement at 1.8 A resolution of the aspartic proteinase from Rhizopus chinensis.

  1987cited by this paper
• alpha-Methylproline-containing renin inhibitory peptides: in vivo evaluation in an anesthetized, ganglion-blocked, hog renin infused rat model.

  1987cited by this paper
• An orally active inhibitor of renin.

  1986cited by this paper
• Design and synthesis of a potent and specific renin inhibitor with a prolonged duration of action in vivo.

  1986cited by this paper
• Construction of a model for the three-dimensional structure of human renal renin.

  1985cited by this paper
• Renin inhibitors. Syntheses of subnanomolar, competitive, transition-state analogue inhibitors containing a novel analogue of statine.

  1985cited by this paper
• Renin inhibitors.

  1984cited by this paper
• Three-dimensional structure of the complex of the Rhizopus chinensis carboxyl proteinase and pepstatin at 2.5-A resolution.

  1982cited by this paper
• Enzymes of the renin-angiotensin system and their inhibitors.

  1982cited by this paper
• Renin-angiotensin system in hypertension.

  1979cited by this paper
• The pathogenesis of chronic renovascular hypertension.

  1977cited by this paper
• Renin-angiotensin system: biochemistry and mechanisms of action.

  1977cited by this paper
• On the size of the active site in proteases. I. Papain.

  1967cited by this paper

• RENIN ANGIOTENSIN SYSTEM IN THE CONTEXT OF RENIN, PRORENIN, AND THE (PRO)RENIN RECEPTOR

  2013cites this paper
• Chapter 11 – Renin

  2013cites this paper
• Two peaks in pH dependence of renin-angiotensinogen reaction.

  1998cites this paper
• Novel small renin inhibitors containing 4,5- or 3,5-dihydroxy-2-substituted-6-phenylhexanamide replacements at the P2-P3 sites.

  1998cites this paper
• 2 Renin Inhibitors

  1995cites this paper
• Overview Cardiovascular & Renal: Recent developments in renin inhibitors: part 1

  1994cites this paper
• Substrate specificity of porcine renin: P1', P1, and P3 residues of renin substrates are crucial for activity.

  1994cites this paper
• Patent Update: Antihypertensive Agents: Recent Advances June through November 1991

  1992cites this paper
• Renin inhibitors. II. Synthesis and structure-activity relationships of N-terminus modified inhibitors containing a homostatine analogue.

  1992cites this paper
• Renin inhibitors. I. Synthesis and structure-activity relationships of transition-state inhibitors containing homostatine analogues at the scissile bond.

  1992cites this paper
• Structure-activity relationships of a series of 2-amino-4-thiazole-containing renin inhibitors.

  1992cites this paper
• Renin inhibitors containing alpha-heteroatom amino acids as P2 residues.

  1992cites this paper
• Peptide Synthesis Gets Friendly

  1991cites this paper
• New inhibitors of human renin that contain novel replacements at the P2 site.

  1991cites this paper
• Renin inhibitors containing esters at the P2-position. Oral activity in a derivative of methyl aminomalonate.

  1991cites this paper
• Determination of dissociation constants of high affinity (pM) human renin inhibitors: application to analogues of ditekiren (U-71,038).

  1991cites this paper
• Chapter 7. Angiotensin / Renin Modulators

  1991cites this paper
• Exploiting the molecular template of angiotensinogen in the discovery and design of peptidyl, pseudopeptidyl and peptidimimetic inhibitors of human renin: a structure-activity perspective.

  1991cites this paper
• Mass-weighted molecular dynamics simulation and conformational analysis of polypeptide.

  1991cites this paper
• Molecular dynamics simulation by atomic mass weighting.

  1990cites this paper